Key result
Review details percutaneous PFO closure therapies alongside the anatomy, pathophysiology, and clinical impact of PFO.
Answers are grounded in this paper and cite their sources.
This review summarizes the anatomy, pathophysiology, clinical impact, and emerging percutaneous treatment options for patent foramen ovale.
Patent foramen ovale (PFO) is experiencing increased clinical interest as a congenital cardiac lesion persisting into adulthood. It is implicated in several serious clinical syndromes, including stroke, myocardial infarction, and systemic embolism. The PFO is now amenable to percutaneous interventional therapies, and multiple novel technologies are either available or under development for lesion closure. The PFO should be better understood to take advantage of emerging percutaneous treatment options. This paper reviews PFO anatomy, pathology, pathophysiology, and clinical impact and discusses current therapeutic options.
No takes yet. Share an insight, caveat, or question.
Hara et al. (2005) conducted a review in Patent foramen ovale. Percutaneous interventional therapies was evaluated. Percutaneous interventional therapies for patent foramen ovale closure are reviewed alongside the anatomy, pathology, pathophysiology, and clinical impact of the condition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: